Healthcare AI reached record-high $846M funding in Q2 2019, report finds

Andrea Park - Print  | 

Startups integrating artificial intelligence into healthcare collectively received a record-breaking amount of funding from venture capital firms in the second quarter of 2019, according to a new report from CB Insights.

The first half of the year has already seen venture funding in healthcare companies reach new highs, according to the Global Healthcare Report, with AI-centric companies no exception. In the second quarter, healthcare AI startups received $864 million in venture capital across a total of 75 deals, up year-over-year from the $764 million the sector earned in the second quarter of 2018.

The report shows that much of the funding went to startups using AI in biotech and biopharma, including a $200 million deal for Chicago-based Tempus, $76 million to San Francisco's BlackThorn Therapeutics and $67 million for South San Francisco-based Frontier Medicines. AI-enabled imaging has also attracted plenty of venture funding; PathAI, a Boston-based developer of AI tools and services for pathology, raised $60 million in April.

More articles on AI:
Mayo Clinic AI detects recent atrial fibrillation in routine ECG
Microsoft leverages blockchain for AI initiatives
Google's AI anticipates 90% of kidney failures up to 48 hours prior to symptoms, study shows

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.